Watch the 22 sessions from SOSV Climate Tech Summit!

Cognitive disorders such as ADHD and Alzheimer’s Disease are two of the most debilitating diseases with dementia alone causing US$680b in global economic impact. Braingaze offers a patented, scientifically and clinically validated biomarker-based decision support system for early diagnosis of dementia and Alzheimer’s and a game based digital treatment that improves patients’ cognitive health. Braingaze is working with 25 clinics and hospitals in Europe and has signed a partnership with Ping An Group for China market entry.

注意力缺陷多动症和阿尔茨海默氏病等认知障碍是两大最令人衰弱的疾病,单就全球痴呆疾病所带来的经济影响就超过6040亿欧元。Braingaze开发了经过专利和科学验证的基于生物标志物的决策支持系统,用于早期客观诊断痴呆症和阿尔茨海默氏症;同时还开发了基于手机应用程序的数字治疗游戏,可以改善患者的认知健康。Braingaze与25家欧洲诊所和医院合作,也与平安集团合作以开拓中国市场。